Article
Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study.
Ophthalmology - 1 Dec 2013
Lotery Andrew J, Gibson Jane, Cree Angela J, Downes Susan M, Harding Simon P, Rogers Chris A, Reeves Barnaby C, Ennis Sarah, Chakravarthy Usha
Abstract excerpt
PURPOSE: To determine if prespecified genetic polymorphisms influence responsiveness to vascular endothelial growth factor (VEGF) inhibition in neovascular age-related macular degeneration (nAMD). The objectives were to replicate 3 reported pharmacogenetic associations of response in nAMD and to test for novel associations. DESIGN: Cohort study, combining information about patients' genotypes with information...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
